High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.1M
$9,134,595
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$417,521x4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $417,521x4 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$499,148x3
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $499,148x3 | S | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Equity Compensation
2025-12-08
$262,806x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2025-12-08 | $262,806x2 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$4,371,833Largex6
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $4,371,833Largex6 | S | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-10-15
$84,185x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-15 | $84,185x2 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-15
$3,659,254Largex4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-15 | $3,659,254Largex4 | S | Form 4 |
|
KYMR
M
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Other
2025-10-13
$2,448x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-13 | $2,448x2 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-13
$186,840
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-13 | $186,840 | S | Form 4 |